The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Insights of Perspectives of Autism Spectrum Disorder
|
|
Author(s): Sapna Sirswal (M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, India), Rajat Goyal (M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, India), Karan Goel (M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, India), Manisha (M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, India), Rupesh K. Gautam (Department of Pharmacology, Indore Institute of Pharmacy, Indore, India)and Sumeet Gupta (M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana-Ambala, India)
Copyright: 2025
Pages: 40
Source title:
Empowering Innovations in Advanced Autism Research and Management
Source Author(s)/Editor(s): Athanasios Alexiou (Department of Research and Development, Funogen, Athens, Greece & Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, Australia), Ghulam Md Ashraf (Department of Biosciences and Bioinformatics, School of Science, Xi’an Jiaotong-Liverpool University, China)and Markos Sgantzos (University of Thessaly, Greece & Hellenic Physical and Rehabilitation Medicine Society, Greece)
DOI: 10.4018/979-8-3693-8176-2.ch001
Purchase
|
Abstract
The complicated neurological disorder known as autism spectrum disorder (ASD) is typified by limited interests and repetitive behaviors in addition to difficulties with social communication. Subtle morphological and functional changes, even in the absence of overt brain pathology, have been observed in several investigations using post-mortem analysis and neuroimaging techniques. While genetic research was previously thought to be useful in defining subtypes, it has primarily produced results that are relevant to a variety of populations that are not exclusively autistic. Accurate clinical assessment and management, which usually start with developmental screening and referral for comprehensive diagnosis, including screening for comorbid conditions, depend on an understanding of and attention to factors affecting prevalence rates, including modifications in diagnostic criteria.ic criteria.
Related Content
|
Kula A. Francis, Kenny A. Hendrickson.
© 2026.
26 pages.
|
|
Summyr Burton, Savannah Baus, Stephen A. Murphy.
© 2026.
50 pages.
|
|
Kesley Richardson, Colby Cavanaugh.
© 2026.
30 pages.
|
|
Angela M. Hill, Kevin B. Sneed, Deborah Austin, Deanna B. Wathington, Hiram B. Green, Michael B. Morgan, Janet B. Roman, Feng B. Cheng, John E. Clark, Natasha Rubie, Kristy Andre, Thea Moore, Antionette Davis, Feng Cheng, Karia Doreen MacAulay, Maisha Standifer, Judette Louis, Joseph Diamond, Kyaien Conner, Victor Obi, Samantha Thompson.
© 2026.
22 pages.
|
|
Angela Stephanie Mazzetti, Anniken Grønstad, John Blenkinsopp.
© 2026.
32 pages.
|
|
Marie Grace Avelino Gomez, Kenith B Villaruel.
© 2026.
30 pages.
|
|
Carolyn Allen.
© 2026.
30 pages.
|
|
|